SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Gregg Lanier, Kedar Sankholkar, Wilbert S. Aronow, Azilsartan, Aliskiren, and Combination Antihypertensives Utilizing Renin–Angiotensin–Aldosterone System Antagonists, American Journal of Therapeutics, 2014, 21, 5, 419

    CrossRef

  2. 2
    Dingliang Zhu, Pingjin Gao, Nobutaka Yagi, Helmut Schumacher, Efficacy and Tolerability of Telmisartan Plus Amlodipine in Asian Patients Not Adequately Controlled on Either Monotherapy or on Low-Dose Combination Therapy, International Journal of Hypertension, 2014, 2014, 1

    CrossRef

  3. 3
    Jan Václavík, Petra Vysočanová, Jitka Seidlerová, Petr Zajíček, Ondřej Petrák, Jaroslav Dlask, Jiří Krýza, Reasons for Switching Antihypertensive Medication in General Practice, Medicine, 2014, 93, 27, e168

    CrossRef

  4. 4
    Ayesha Salahuddin, Muzammil Mushtaq, Barry J. Materson, Combination therapy for hypertension 2013: An update, Journal of the American Society of Hypertension, 2013, 7, 5, 401

    CrossRef

  5. 5
    S. Neldam, B. Dahlöf, W. Oigman, H. Schumacher, Early combination therapy with telmisartan plus amlodipine for rapid achievement of blood pressure goals, International Journal of Clinical Practice, 2013, 67, 9
  6. 6
    Mitsuru Ohishi, Tatsuo Kawai, Norihiro Hayashi, Shoichi Kitano, Tomohiro Katsuya, Masahiro Nagano, Atsushi Hirotani, Koichi Yamamoto, Kei Kamide, Hiromi Rakugi, Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study, Hypertension Research, 2013, 36, 7, 620

    CrossRef

  7. 7
    Hanke Mollnau, Matthias Oelze, Elena Zinßius, Michael Hausding, Zhixiong Wu, Maike Knorr, Jasmin Ghaemi Kerahrodi, Swenja Kröller-Schön, Thomas Jansen, Christine Teutsch, Carolyn Foster, Huige Li, Philip Wenzel, Eberhard Schulz, Thomas Münzel, Andreas Daiber, Effects of telmisartan or amlodipine monotherapy versus telmisartan/amlodipine combination therapy on vascular dysfunction and oxidative stress in diabetic rats, Naunyn-Schmiedeberg's Archives of Pharmacology, 2013, 386, 5, 405

    CrossRef

  8. 8
    Steen Neldam, Dingliang Zhu, Helmut Schumacher, Efficacy of Telmisartan Plus Amlodipine in Nonresponders to CCB Monotherapy, International Journal of Hypertension, 2013, 2013, 1

    CrossRef

  9. 9
    Ludwin Ley, Helmut Schumacher, Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients), Current Medical Research and Opinion, 2013, 29, 1, 41

    CrossRef

  10. 10
    Joel M Neutel, Treatment algorithms for hypertension: a practical approach, Clinical Practice, 2013, 10, 3, 333

    CrossRef

  11. 11
    Boon How Chew, Ismail Mastura, Sazlina Shariff-Ghazali, Ping Yein Lee, Ai Theng Cheong, Zaiton Ahmad, Sri Taher, Jamaiyah Haniff, Feisul Mustapha, Mohd Bujang, Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009, Cardiovascular Diabetology, 2012, 11, 1, 54

    CrossRef

  12. 12
    Sripal Bangalore, Ludwin Ley, Improving treatment adherence to antihypertensive therapy: the role of single-pill combinations, Expert Opinion on Pharmacotherapy, 2012, 13, 3, 345

    CrossRef

  13. 13
    Steen Neldam, Colin Edwards, Margreet Lang, Russell Jones, Long-Term Tolerability and Efficacy of Single-Pill Combinations of Telmisartan 40–80 mg Plus Amlodipine 5 or 10 mg in Patients Whose Blood Pressure Was Not Initially Controlled by Amlodipine 5–10 mg: Open-Label, Long-Term Follow-Ups of the TEAMSTA-5 and TEAMSTA-10 Studies, Current Therapeutic Research, 2012, 73, 1-2, 65

    CrossRef

  14. 14
    Arya M. Sharma, George Bakris, Joel M. Neutel, Thomas W. Littlejohn, Maureen Kobe, Naitee Ting, Ludwin Ley, Single-Pill Combination of Telmisartan/Amlodipine Versus Amlodipine Monotherapy in Diabetic Hypertensive Patients: An 8-Week Randomized, Parallel-Group, Double-Blind Trial, Clinical Therapeutics, 2012, 34, 3, 537

    CrossRef